Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease

INTRODUCTION: Synaptic dysfunction and degeneration is one of the earliest events in Alzheimer's disease (AD) and the best correlate of cognitive decline. Thus, identification and validation of biomarkers reflecting synaptic degeneration to be used as prognostic biomarkers are greatly needed. M...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Alzheimers Dement (Amst)
Päätekijät: Nilsson, Johanna, Gobom, Johan, Sjödin, Simon, Brinkmalm, Gunnar, Ashton, Nicholas J., Svensson, Johan, Johansson, Per, Portelius, Erik, Zetterberg, Henrik, Blennow, Kaj, Brinkmalm, Ann
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2021
Aiheet:
Cerebrospinal Fluid Biomarkers
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8087978/
https://ncbi.nlm.nih.gov/pubmed/33969172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/dad2.12179
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia